Bowering, K., Harvey, J., Kolaczynski, J. W., Snyder, J. W., & Bode, B. W. (2018). Mealtime fast‐acting insulin aspart versus insulin aspart for controlling postprandial hyperglycaemia in people with insulin‐resistant Type 2 diabetes. Diabet Med.

Bowering, K., J. Harvey, J. W. Kolaczynski, J. W. Snyder, and B. W. Bode. "Mealtime Fast‐acting Insulin Aspart Versus Insulin Aspart for Controlling Postprandial Hyperglycaemia in People With Insulin‐resistant Type 2 Diabetes." Diabet Med 2018.

Bowering, K., et al. "Mealtime Fast‐acting Insulin Aspart Versus Insulin Aspart for Controlling Postprandial Hyperglycaemia in People With Insulin‐resistant Type 2 Diabetes." Diabet Med 2018.